• Blau Farmacêutica held a board meeting on Aug. 11, 2026, via videoconference, focused on 2Q26 financial reporting.
• The board cleared the financial statements, quarterly information, and explanatory notes for the quarter ended June 30, 2026.
• Management was authorized to take the required steps to disclose the approved quarterly financial information.
• Directors also acknowledged receipt of the Audit and Ethics Committee’s quarterly report covering its 2Q26 activities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blau Farmaceutica SA published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.